Flanagan SD - Search Results

1

Safety, tolerability, QTc evaluation, and pharmacokinetics of single and multiple doses of enzastaurin HCl (LY317615), a protein kinase C-beta inhibitor, in healthy subjects.

Welch PA, Sinha VP, Cleverly AL, Darstein C, Flanagan SD, Musib LC. Welch PA, et al. Among authors: flanagan sd. J Clin Pharmacol. 2007 Sep;47(9):1138-51. doi: 10.1177/0091270007304775. J Clin Pharmacol. 2007. PMID: 17766700 Clinical Trial.

2

Clinical pharmacokinetics of alamifovir and its metabolites.

Chan C, Abu-Raddad E, Golor G, Watanabe H, Sasaki A, Yeo KP, Soon D, Sinha VP, Flanagan SD, He MM, Wise SD. Chan C, et al. Among authors: flanagan sd. Antimicrob Agents Chemother. 2005 May;49(5):1813-22. doi: 10.1128/AAC.49.5.1813-1822.2005. Antimicrob Agents Chemother. 2005. PMID: 15855501 Free PMC article. Clinical Trial.

3

Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate in Elderly Subjects.

Flanagan SD, Minassian SL, Prokocimer P. Flanagan SD, et al. Clin Pharmacol Drug Dev. 2018 Sep;7(7):788-794. doi: 10.1002/cpdd.426. Epub 2018 Jan 10. Clin Pharmacol Drug Dev. 2018. PMID: 29319932 Clinical Trial.

4

A phase I randomized, double-blind, single subcutaneous dose escalation study to determine the safety, tolerability, and pharmacokinetics of rezafungin in healthy adult subjects.

Gu K, Ruff D, Key C, Thompson M, Jiang S, Sandison T, Flanagan S. Gu K, et al. Clin Transl Sci. 2022 Jul;15(7):1592-1598. doi: 10.1111/cts.13286. Epub 2022 May 4. Clin Transl Sci. 2022. PMID: 35439347 Free PMC article. Clinical Trial.

5

Lack of Effect of Rezafungin on QT/QTc Interval in Healthy Subjects.

Flanagan S, Goodman DB, Jandourek A, O'Reilly T, Sandison T. Flanagan S, et al. Clin Pharmacol Drug Dev. 2020 May;9(4):456-465. doi: 10.1002/cpdd.757. Epub 2019 Dec 2. Clin Pharmacol Drug Dev. 2020. PMID: 31793231 Clinical Trial.

6

Pharmacokinetics of Tedizolid in Obese and Nonobese Subjects.

Flanagan S, Minassian SL, Passarell JA, Fiedler-Kelly J, Prokocimer P. Flanagan S, et al. J Clin Pharmacol. 2017 Oct;57(10):1290-1294. doi: 10.1002/jcph.928. Epub 2017 May 16. J Clin Pharmacol. 2017. PMID: 28510339 Clinical Trial. No abstract available.

7

Pharmacokinetics and pharmacodynamics of exenatide extended-release after single and multiple dosing.

Fineman M, Flanagan S, Taylor K, Aisporna M, Shen LZ, Mace KF, Walsh B, Diamant M, Cirincione B, Kothare P, Li WI, MacConell L. Fineman M, et al. Clin Pharmacokinet. 2011 Jan;50(1):65-74. doi: 10.2165/11585880-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21142268

8

Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid.

Flanagan S, Fang E, Muñoz KA, Minassian SL, Prokocimer PG. Flanagan S, et al. Pharmacotherapy. 2014 Sep;34(9):891-900. doi: 10.1002/phar.1458. Epub 2014 Jul 3. Pharmacotherapy. 2014. PMID: 24989138 Free PMC article. Clinical Trial.

9

Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents.

Bradley JS, Flanagan SD, Arrieta AC, Jacobs R, Capparelli E, Prokocimer P. Bradley JS, et al. Among authors: flanagan sd. Pediatr Infect Dis J. 2016 Jun;35(6):628-33. doi: 10.1097/INF.0000000000001096. Pediatr Infect Dis J. 2016. PMID: 26910588 Clinical Trial.

10

Pharmacokinetics of Tedizolid and Pseudoephedrine Administered Alone or in Combination in Healthy Volunteers.

Flanagan S, Minassian SL, Prokocimer P. Flanagan S, et al. J Clin Med. 2018 Jun 14;7(6):150. doi: 10.3390/jcm7060150. J Clin Med. 2018. PMID: 29899212 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters